Wednesday, October 21, 2026

12:25 PM - 1:10 PM

Investment & Global Growth Breakout Room

---

Details

Artificial intelligence is transforming more than the companies investors back - it's reshaping how investment decisions are made. From sourcing opportunities and analysing scientific literature to commercial diligence, market mapping and portfolio support, AI is rapidly becoming part of the modern investment toolkit. At the same time, AI-native therapeutics, diagnostics and drug discovery platforms are redefining what investors are looking for and how value is created. Bringing together venture investors, pharmaceutical leaders and technology experts, this panel will explore how AI is changing investment workflows today, where it creates genuine competitive advantage, and what the next generation of biotech investing could look like. Join us for a practical discussion on the opportunities, limitations and future implications of AI for investors, founders and the broader life sciences ecosystem

---

Speaker